Johnson & Johnson's $13b bid to settle cancer claims a 'massive gamble'
Johnson & Johnson’s first attempt at using bankruptcy to escape claims that its popular baby powder caused cancer was an expensive tactic that drew public scorn and ended in failure. Now it is trying again.